SCHEMBL2409883

SCHEMBL2409883

CCOc1nc(-c2cccc(Cc3ccccc3)n2)nc2sccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.36
BRD4 O60885 1/20 0.36
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 1/20 0.36
PKM P14618 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
POLB P06746 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
ADORA2A P29274 6/20 0.35
ADORA1 P30542 3/20 0.35
USP1 O94782 1/20 0.35
WDR48 Q8TAF3 1/20 0.35
RAB9A P51151 1/20 0.34
HTR2C P28335 1/20 0.34
GAA P10253 1/20 0.34
SQOR Q9Y6N5 1/20 0.33
PDE5A O76074 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2414877 0.89 KMT2A (0.39) KMT2ABRD4MAPTSMN1; SMN2ALDH1A1
SCHEMBL8779414 0.82 MEN1 (0.54) KMT2AMEN1BRD4MAPTALDH1A1
SCHEMBL2407988 0.80 ADORA2A (0.43) BRD4MAPTSMN1; SMN2ALDH1A1PKM
SCHEMBL14038326 0.80 KRAS (0.46) KMT2AMEN1MAPTALDH1A1L3MBTL1
SCHEMBL2413283 0.75 BRD4 (0.35) BRD4MAPTSMN1; SMN2ALDH1A1PKM
SCHEMBL8779425 0.74 GAA (0.51) KMT2AMEN1MAPTALDH1A1L3MBTL1
SCHEMBL8779416 0.70 PDE5A (0.45) KMT2AMEN1BRD4MAPTALDH1A1
SCHEMBL3787489 0.70 MAPT (0.50) KMT2AMEN1MAPTALDH1A1L3MBTL1
SCHEMBL2408334 0.69 KRAS (0.60) KMT2AMEN1MAPTSMN1; SMN2ALDH1A1
SCHEMBL8779404 0.69 PDE5A (0.43) KMT2AMEN1BRD4MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2539338-A1 NOVEL MICROBICIDES Syngenta Participations AG (CH) 2013-01-02 EP disclosed
US-20120316184-A1 NOVEL MICROBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-12-13 US disclosed
US-20120316184-A1 NOVEL MICROBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-12-13 US disclosed
US-20120316184-A1 NOVEL MICROBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-12-13 US disclosed
WO-2011104183-A1 NOVEL MICROBICIDES SYNGENTA PARTICIPATIONS AG (CH) 2011-09-01 WO disclosed
WO-2011104183-A1 NOVEL MICROBICIDES SYNGENTA PARTICIPATIONS AG (CH) 2011-09-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120316184-A1 NOVEL MICROBICIDES NOX1, MSR1, FPR1 KMT2A 4364/4885MEN1 2304/4885BRD4 2021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.